CD3 TARGETING ANTIBODIES AND USES THEREOF

The present disclosure relates generally to immunoglobulin-related compositions (e.g., antibodies or antigen binding fragments thereof) that can bind to the CD3 protein. The antibodies of the present technology are useful in methods for detecting CD3 and treating cancer in a subject in need thereof.

Saved in:
Bibliographic Details
Main Authors PELZEK, ADAM, MUDA, MARCO, MURPHY, SHAUN, LULO, JAMES
Format Patent
LanguageEnglish
French
Published 09.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates generally to immunoglobulin-related compositions (e.g., antibodies or antigen binding fragments thereof) that can bind to the CD3 protein. The antibodies of the present technology are useful in methods for detecting CD3 and treating cancer in a subject in need thereof.
Bibliography:Application Number: CA20223228257